Compass Therapeutics, Inc. (CMPX) Reports In-Line Q2 EPS

Go back to Compass Therapeutics, Inc. (CMPX) Reports In-Line Q2 EPS
(NASDAQ: CMPX) Delayed: 2.02 -0.03 (1.46%)
Previous Close $2.05    52 Week High
Open $2.08    52 Week Low
Day High $2.13    P/E N/A 
Day Low $2.00    EPS
Volume 9,276,475